Bliss GVS Pharma's Stock Sees -10.31% Decline, Rated 'Hold' by MarketsMOJO

Bliss GVS Pharma, a smallcap pharmaceutical company, saw a decline of -10.31% in its stock price on October 25, 2024. The stock has been on a downward trend for the past two days, falling by -11.62% during this period. It touched an intraday low of Rs 109.2, showing high volatility with an intraday range of 5.25%.

According to MarketsMOJO, a leading stock analysis platform, the stock is currently rated as 'Hold'. It is also a part of the Hidden Turnaround list on MarketsMOJO since November 2, 2023.

In terms of performance, Bliss GVS Pharma has underperformed the sector by -9.77% today. It is also trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages.

Comparing its performance to the Sensex, Bliss GVS Pharma has seen a decline of -10.92% in the past day, while the Sensex has shown a minimal increase of 0.03%. In the past month, the stock has seen a decline of -19.66%, while the Sensex has also shown a negative performance of -5.97%.

Overall, Bliss GVS Pharma's stock has been on a downward trend and is currently rated as 'Hold' by MarketsMOJO. Investors should keep an eye on the stock's performance and monitor any changes in the coming days.